Blogger Larry Husten asks, “Why was an Abbott marketing study published in the American Journal of Cardiology?” It’s a great example of some of the fine journalism done by some blogging health journalists.
On MedPageToday.com, physician-bioethicist Jeffrey Hall Dobken suggests that “perhaps we can tone down the sky-is-falling just a bit” on H1N1. And he includes news coverage in his review of the “tension…reinforced by the endless health warnings.”
CBS News last night proclaimed the drug peramavir as a “lifesaving drug” for serious cases of H1N1 infection. Lines from the story: • “Experts caution its too early to see Peramivir as a miracle drug, but there’s no doubting the drugs connection to some miraculous results.” • “Human clinical trials in the U.S. and Japan [...]
CBS’ Harry Smith. CNN’s Sanjay Gupta. Some UK reporter. Hasn’t anyone from The Onion been stricken yet? Stay tuned for next week’s episode: “The cure for journalistic narcissism.”
As our review on HealthNewsReview.org said… The story noted that people should make vaccination decisions with good information. Unfortunately it didn’t provide much. A confusing jumble lacking appropriate context.
Interesting look at international coverage of the H1N1 flu story in a new analysis by the Project for Excellence in Journalism. They studied 12 days of front-page newspaper coverage in seven countries around the world. Key points from their summary: • The three major U.S. papers studied offered some of the broadest coverage of the [...]